Pennington, NJ, United States of America

Miles Augustus Libbey, Iii

This inventor holds 4 USPTO granted patents. Top assignees: Delrx Pharmaceutical Corporation, Mqs, Inc., Other. Active years: 2002-2003.


% Patents Active = 75.0

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 131(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Miles Augustus Libbey, III: Innovator in Pharmaceutical Formulations

Introduction

Miles Augustus Libbey, III is a notable inventor based in Pennington, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, holding a total of 4 patents. His work focuses on innovative methods for administering pharmaceutical agents effectively.

Latest Patents

Among his latest patents is a formulation for administering calcitonin, which provides a non-invasive method for delivering polypeptides across epithelial membranes. This invention includes solid polypeptide particles mixed with a permeation enhancer and excipients, designed for oral or intranasal administration. Another significant patent is for a formulation and system for intra-oral delivery of pharmaceutical agents. This stable formulation enables effective delivery of pharmaceutical agents through the oral cavity, utilizing an oral-absorption enhancer to improve absorption through the surface membrane.

Career Highlights

Miles has worked with Delrx Pharmaceutical Corporation, where he applied his expertise in pharmaceutical innovations. His career reflects a commitment to advancing drug delivery systems and improving patient outcomes through innovative formulations.

Collaborations

He has collaborated with notable individuals in the field, including Randall Eugene McCoy and Robert O. Williams, III. These partnerships have contributed to the development of his groundbreaking inventions.

Conclusion

Miles Augustus Libbey, III is a distinguished inventor whose work in pharmaceutical formulations has the potential to transform drug delivery methods. His innovative patents reflect a dedication to enhancing the efficacy of treatments for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…